• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

人类肿瘤的生长速率:第二部分。

Rates of growth of human neoplasms: Part II.

作者信息

Spratt J S, Meyer J S, Spratt J A

机构信息

Department of Surgery, James Graham Brown Cancer Center, University of Louisville School of Medicine, KY 40202, USA.

出版信息

J Surg Oncol. 1996 Jan;61(1):68-83. doi: 10.1002/1096-9098(199601)61:1<68::aid-jso2930610102>3.0.co;2-e.

DOI:10.1002/1096-9098(199601)61:1<68::aid-jso2930610102>3.0.co;2-e
PMID:8544465
Abstract

Part I of this study [Spratt JS, Meyer JS, Spratt JA: J Surg Oncol 60:137-146, 1995] reviewed the early reports of investigators, predominantly mathematical biologists and statisticians considering the mathematical laws that would describe the growth of a neoplasm. Included were cytokinetic measurements of the mitotic index, thymidine labeling index, bromodeoxy-uridine labeling index, and the relation of these indices to the potential tumor volume doubling time. The actual doubling time of benign and malignant colonic neoplasms were reported. This second part provides the cumulative observations on the actual doubling times of pulmonary metastases, primary pulmonary cancers, skeletal sarcomas, melanomas, a chemodectoma, tumors of maxillary antrum, testicular cancers, prostate cancer, and the relation between the accumulation of multiple primary cancers and growth rates. The most complete data set is for breast cancer concluding that the cancer growth curve is a decelerating curve with great natural variance. Understanding of the rates of growth of human cancers is essential for understanding the spectrum of cancer behavior observed clinically.

摘要

本研究的第一部分[斯普拉特JS、迈耶JS、斯普拉特JA:《外科肿瘤学杂志》60:137 - 146,1995年]回顾了研究人员的早期报告,这些研究人员主要是数学生物学家和统计学家,他们思考描述肿瘤生长的数学规律。其中包括有丝分裂指数、胸腺嘧啶核苷标记指数、溴脱氧尿苷标记指数的细胞动力学测量,以及这些指数与潜在肿瘤体积倍增时间的关系。报告了良性和恶性结肠肿瘤的实际倍增时间。第二部分提供了关于肺转移瘤、原发性肺癌、骨肉瘤、黑色素瘤、化学感受器瘤、上颌窦肿瘤、睾丸癌、前列腺癌实际倍增时间的累积观察结果,以及多发性原发性癌症的累积与生长速率之间的关系。关于乳腺癌的数据集最为完整,得出的结论是癌症生长曲线是一条具有很大自然变异性的减速曲线。了解人类癌症的生长速率对于理解临床上观察到的癌症行为谱至关重要。

相似文献

1
Rates of growth of human neoplasms: Part II.人类肿瘤的生长速率:第二部分。
J Surg Oncol. 1996 Jan;61(1):68-83. doi: 10.1002/1096-9098(199601)61:1<68::aid-jso2930610102>3.0.co;2-e.
2
On the growth rates of human malignant tumors: implications for medical decision making.关于人类恶性肿瘤的生长速率:对医疗决策的影响
J Surg Oncol. 1997 Aug;65(4):284-97. doi: 10.1002/(sici)1096-9098(199708)65:4<284::aid-jso11>3.0.co;2-2.
3
Rates of growth of human solid neoplasms: Part I.人类实体瘤的生长速率:第一部分
J Surg Oncol. 1995 Oct;60(2):137-46. doi: 10.1002/jso.2930600216.
4
Growth rate of lung metastases and S-phase fraction as determined by flow cytometry from the primary tumour in 25 patients with bone or soft-tissue sarcomas.25例骨或软组织肉瘤患者的原发性肿瘤经流式细胞术测定的肺转移生长速率和S期细胞分数。
Br J Cancer. 1996 Jun;73(12):1556-9. doi: 10.1038/bjc.1996.293.
5
[Chemodectoma of the glomus jugulare with multiple metastases. Case report].[颈静脉球化学感受器瘤伴多发转移。病例报告]
Neurol Med Chir (Tokyo). 1986 Sep;26(9):701-5. doi: 10.2176/nmc.26.701.
6
Minute pulmonary chemodectoma.微小肺化学感受器瘤
Cancer. 1971 Sep;28(3):692-700. doi: 10.1002/1097-0142(197109)28:3<692::aid-cncr2820280326>3.0.co;2-e.
7
[Radiosensitivity of bone metastases from tumors in different primary sites].[不同原发部位肿瘤骨转移灶的放射敏感性]
Vopr Onkol. 2015;61(1):77-84.
8
Cytokinetic definition of acute and chronic breast cancer.急性和慢性乳腺癌的细胞动力学定义
Cancer Res. 1977 Jan;37(1):226-30.
9
[Growth rate of pulmonary metastases (author's transl)].肺转移瘤的生长速率(作者译)
Strahlentherapie. 1979 Nov;155(11):748-53.
10
Solitary pulmonary nodules in patients with extrapulmonary neoplasms.肺外肿瘤患者的孤立性肺结节。
Radiology. 2000 Oct;217(1):257-61. doi: 10.1148/radiology.217.1.r00oc20257.

引用本文的文献

1
Evolutionary rescue by aneuploidy in tumors exposed to anticancer drugs.非整倍体在暴露于抗癌药物的肿瘤中的进化拯救作用。
Genetics. 2025 Jul 9;230(3). doi: 10.1093/genetics/iyaf098.
2
Tumour growth rate and invasive interval cancer characteristics in a UK breast cancer screening population.英国乳腺癌筛查人群中的肿瘤生长速率及浸润期癌症特征
Eur Radiol. 2025 Jan 21. doi: 10.1007/s00330-024-11342-x.
3
Predicting Tumor Volume Doubling Time and Progression-Free Survival in Untreated Patients from Patient-Derived-Xenograft (PDX) Models: A Translational Model-Based Approach.
从患者来源的异种移植(PDX)模型预测未经治疗的患者的肿瘤倍增时间和无进展生存期:一种基于转化模型的方法。
AAPS J. 2024 Aug 8;26(5):92. doi: 10.1208/s12248-024-00960-4.
4
The prognostic potential of mammographic growth rate of invasive breast cancer in the Nijmegen breast cancer screening cohort.乳腺 X 线摄影检查中浸润性乳腺癌生长率的预后预测价值:奈梅亨乳腺癌筛查队列研究
J Med Screen. 2024 Sep;31(3):166-175. doi: 10.1177/09691413231222765. Epub 2024 Jan 31.
5
Susceptibility Genes Associated with Multiple Primary Cancers.与多发性原发性癌症相关的易感基因。
Cancers (Basel). 2023 Dec 10;15(24):5788. doi: 10.3390/cancers15245788.
6
A Case of -Pathogenic Variant Breast Cancer With Metachronous Endometrial Cancer and Pancreatic Cancer.一例伴有异时性子宫内膜癌和胰腺癌的致病性变异型乳腺癌病例。
World J Oncol. 2023 Aug;14(4):309-315. doi: 10.14740/wjon1658. Epub 2023 Aug 4.
7
Significance of circulating tumor cells in lung cancer: a narrative review.循环肿瘤细胞在肺癌中的意义:一篇叙述性综述。
Transl Lung Cancer Res. 2023 Apr 28;12(4):877-894. doi: 10.21037/tlcr-22-712. Epub 2023 Mar 29.
8
Dissecting sources of variability in patient response to targeted therapy: anti-HER2 therapies as a case study.剖析患者对靶向治疗反应的变异性来源:以抗 HER2 治疗为例。
Eur J Pharm Sci. 2023 Jul 1;186:106467. doi: 10.1016/j.ejps.2023.106467. Epub 2023 May 16.
9
A phenomenological model for COVID-19 data taking into account neighboring-provinces effect and random noise.一种考虑邻省效应和随机噪声的新冠肺炎数据现象学模型。
Stat Neerl. 2022 Oct 5. doi: 10.1111/stan.12278.
10
Tumor growth monitoring in breast cancer xenografts: A good technique for a strong ethic.乳腺癌异种移植中的肿瘤生长监测:一种强大伦理学的良好技术。
PLoS One. 2022 Sep 30;17(9):e0274886. doi: 10.1371/journal.pone.0274886. eCollection 2022.